Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial.
Litwin AH, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo M, Arnsten J, Meissner P, Karasz A, Mckee MD, Ward JW, Johnson N, Pericot-Valverde I, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Roche J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Page K; HERO Study Group. Litwin AH, et al. Among authors: kim ay. Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1112-1127. doi: 10.1016/S2468-1253(22)00275-8. Lancet Gastroenterol Hepatol. 2022. PMID: 36370741 Clinical Trial.
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study.
Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J; InC(3)Study Group. Hajarizadeh B, et al. Among authors: kim ay. J Clin Virol. 2014 Nov;61(3):430-4. doi: 10.1016/j.jcv.2014.08.027. Epub 2014 Sep 8. J Clin Virol. 2014. PMID: 25256151 Free PMC article.
Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study.
Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J; InC3 Study Group. Hajarizadeh B, et al. Among authors: kim ay. J Viral Hepat. 2015 Sep;22(9):708-17. doi: 10.1111/jvh.12384. Epub 2015 Jan 8. J Viral Hepat. 2015. PMID: 25580520 Free PMC article.
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J; International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3 Study). Spelman T, et al. Among authors: kim ay. J Epidemiol Community Health. 2015 Aug;69(8):745-52. doi: 10.1136/jech-2014-205224. Epub 2015 Mar 26. J Epidemiol Community Health. 2015. PMID: 25814695 Free PMC article.
Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.
Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ; InC3 Study Group. Doyle JS, et al. Among authors: kim ay. J Viral Hepat. 2015 Dec;22(12):1020-32. doi: 10.1111/jvh.12429. Epub 2015 Jun 22. J Viral Hepat. 2015. PMID: 26098993 Free PMC article.
Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study.
Rodrigo C, Eltahla AA, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Shoukry NH, Lauer GM, Maher L, Schinkel J, Prins M, Hellard M, Lloyd AR; InC3 Collaborative. Rodrigo C, et al. Among authors: kim ay. J Viral Hepat. 2017 Jan;24(1):43-52. doi: 10.1111/jvh.12616. Epub 2016 Nov 3. J Viral Hepat. 2017. PMID: 27808453 Free PMC article.
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection.
Matthews GV, Bhagani S, Van der Valk M, Rockstroh J, Feld JJ, Rauch A, Thurnheer C, Bruneau J, Kim A, Hellard M, Shaw D, Gane E, Nelson M, Ingiliz P, Applegate TL, Grebely J, Marks P, Martinello M, Petoumenos K, Dore GJ; REACT study group; Protocol Steering Committee; Coordinating Centre; Site Principal Investigators. Matthews GV, et al. J Hepatol. 2021 Oct;75(4):829-839. doi: 10.1016/j.jhep.2021.04.056. Epub 2021 May 21. J Hepatol. 2021. PMID: 34023350 Free PMC article.
The experience of re-infection among people who inject drugs successfully treated for hepatitis C.
Karasz A, Merchant K, Singh R, Thomas A, Borsuk C, McKee D, Duryea P, Kim AY, Mehta S, Norton BL, Page K, Pericot-Valverde I, Sedillo S, Stein ES, Taylor LE, Tsui J, Litwin A. Karasz A, et al. Among authors: kim ay. J Subst Use Addict Treat. 2023 Mar;146:208937. doi: 10.1016/j.josat.2022.208937. Epub 2023 Jan 6. J Subst Use Addict Treat. 2023. PMID: 36880897
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs.
Tsui JI, Lum PJ, Taylor LE, Mehta SH, Feinberg J, Kim AY, Norton BL, Niu J, Heo M, Arnsten J, Pericot-Valverde I, Thomas A, Blalock KL, Radick A, Murray-Krezan C, Page K, Litwin AH; HERO Study Group. Tsui JI, et al. Among authors: kim ay. Drug Alcohol Depend. 2023 Jun 1;247:109878. doi: 10.1016/j.drugalcdep.2023.109878. Epub 2023 Apr 17. Drug Alcohol Depend. 2023. PMID: 37150144 Clinical Trial.
777 results